BioForce Nanosciences Company Top Insiders
| BFNH Stock | USD 0.34 0.25 42.37% |
BioForce Nanosciences employs about 2 people. The company is managed by 4 executives with a total tenure of roughly 5 years, averaging almost 1.0 years of service per executive, having 0.5 employees per reported executive. Assessment of BioForce Nanosciences' management performance can provide insight into the firm performance.
| Steven Gagnon Insider CoChief Officer |
| Richard Kaiser Insider Corp CFO |
BioForce |
BioForce Nanosciences Management Team Effectiveness
The company has return on total asset (ROA) of (21.8443) % which means that it has lost $21.8443 on every $100 spent on assets. This is way below average. BioForce Nanosciences' management efficiency ratios could be used to measure how well BioForce Nanosciences manages its routine affairs as well as how well it operates its assets and liabilities.BioForce Nanosciences Workforce Comparison
BioForce Nanosciences Holdings is rated below average in number of employees category among its peers. The total workforce of Packaged Foods industry is currently estimated at about 160. BioForce Nanosciences claims roughly 2.0 in number of employees contributing just under 2% to equities listed under Packaged Foods industry.
BioForce Nanosciences Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. BioForce Nanosciences Price Series Summation is a cross summation of BioForce Nanosciences price series and its benchmark/peer.
BioForce Nanosciences Notable Stakeholders
A BioForce Nanosciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as BioForce Nanosciences often face trade-offs trying to please all of them. BioForce Nanosciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting BioForce Nanosciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Steven Gagnon | CoChief Officer | Profile | |
| Richard Kaiser | Corp CFO | Profile | |
| Aleksandr Shapiro | President | Profile | |
| John LaViolette | CoChief Officer | Profile |
About BioForce Nanosciences Management Performance
The success or failure of an entity such as BioForce Nanosciences often depends on how effective the management is. BioForce Nanosciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BioForce management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BioForce management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, and mass merchandisers under the BioForce Eclipse brand, as well as through online and telemarketing. BIOFORCE NANOSCIENCES operates under Packaged Foods classification in the United States and is traded on OTC Exchange. It employs 2 people.
BioForce Nanosciences Workforce Analysis
Traditionally, organizations such as BioForce Nanosciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare BioForce Nanosciences within its industry.BioForce Nanosciences Manpower Efficiency
Return on BioForce Nanosciences Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 251K | |
| Net Loss Per Executive | 125.5K | |
| Working Capital Per Employee | 7K | |
| Working Capital Per Executive | 3.5K |
Complementary Tools for BioForce Pink Sheet analysis
When running BioForce Nanosciences' price analysis, check to measure BioForce Nanosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioForce Nanosciences is operating at the current time. Most of BioForce Nanosciences' value examination focuses on studying past and present price action to predict the probability of BioForce Nanosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioForce Nanosciences' price. Additionally, you may evaluate how the addition of BioForce Nanosciences to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stocks Directory Find actively traded stocks across global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |